Portal de Periódicos da CAPES

Is Prophylactic Immunostimulation of the Host against Pathogenic Microbial Antigens an Adequate Strategy of Immunoprotection?

1992; Wiley; Volume: 35; Issue: 5 Linguagem: Inglês

10.1111/j.1365-3083.1992.tb03247.x

1365-3083

Mário Arala‐Chaves,

Immune responses and vaccinations

Scandinavian Journal of ImmunologyVolume 35, Issue 5 p. 495-500 Is Prophylactic Immunostimulation of the Host against Pathogenic Microbial Antigens an Adequate Strategy of Immunoprotection? M.P. Arala-Chaves, M.P. Arala-Chaves Department of Immunology, Institute for Biomedical Sciences abel Salazar, Largo do Prof. Abel Salazar, 2,4000 Porto, PortugalSearch for more papers by this author M.P. Arala-Chaves, M.P. Arala-Chaves Department of Immunology, Institute for Biomedical Sciences abel Salazar, Largo do Prof. Abel Salazar, 2,4000 Porto, PortugalSearch for more papers by this author First published: May 1992 https://doi.org/10.1111/j.1365-3083.1992.tb03247.xCitations: 8AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Reference 1 Warren KS. New scientific opportunities and old 2 obstacles in vaccine development. Proc Natl Acad Sci USA 1986; 83: 9275–7. 2 Fine PEM. The BCG story: lessons from the past and implications for the future. Rev Infect Dis II Suppl 1989; 2: 353–9. 3 Fleisher TA, Greene WC, Uchiyama T et al. Characterization of a soluble suppressor of human B cell immunoglobulin biosynthesis produced by a continuous human suppressor T cell line. J Exp Med 1981; 154: 156–67. 4 Beckwith M, Rich S. Suppressive mechanisms in alloantigen-induced T cell responses. J Exp Med 1983; 158: 1853–67. 5 Thoman ML, Weigle WO. Deficiency in suppressor T cell activity in aged animals. Reconstruction of this activity by interleukin 2. J Exp Med 1983; 157: 2184–9. 6 Howard M, Mizel SB, Lachman L, Ansel J, Johnson B, Paul WL. Role of interleukin I in anti-immuno-globulin-induced B cell proliferation. J Exp Med 1983; 157: 1529–43. 7 Liew FY, Howard JG. Regulation of delayed-type hypersensitivity. V. Suppressor cell memory in antigen-specific suppression of delayed-type hyper-sensitivity to sheep erythrocytes. Eur J Immunol 1980; 10: 937–43. 8 Schwenk RJ, Kudo K, Miyamoto M, Sehon AH. Regulation of the murine IgE antibody response. I. Characterization of suppressor cells regulating both persistent and transient responses and their sensitivity to low doses of X-irradiation. J Immunol 1979; 123: 2791–8. 9 Kleinherzs ME, Ellner JJ, Spagnulo PJ, Daniel TM. Suppression of lymphocyte responses by tuberculous plasma and mycobacteriae arabinogalactan. Monocyte dependence and indomethacin reversibility. J Clin Invest 1981; 68: 153–62. 10 Arala-Chaves MP, Korn JH, Galbraith GMP, Porto MT, Smith CL, Fundenberg HH. Effects of thymosin and evidence of monocyte suppression of both T- and B-cell functions in two cases of “common variable immunodeficiency”. Scand J Immunol 1982; 15: 97–104. 11 Citron MO, Michael JG. Regulation of the immune response to bacterial lipopolysaccharide by adherent cells. Infect Immun 1981; 23: 519–22. 12 Morimoto C, Reinherz EL, Todd RF, Distaso JA, Schlossman SF. Generation of antigen-specific suppression cells in vitro in man. J Immunol 1983; 131: 1209–13. 13 Boraschi D, Niederhuber JE. Regulation of macrophage suppression and cytotoxicity by interferon: role of la-bearing macrophages. J Immunol 1982; 129: 1854–8. 14 Britz JS, Askenase PW, Ptak W, Steinman RM, Gershon RK. Specialized antigen-presenting cells, splenic dendritic cells and peritoneal-exudate cells induced by mycobacteria activate effector T cells that are resistant to suppression. J Exp Med 1982; 155: 1344–6. 15 Van Voorhis WC, Valinsky J, Hoffman E, Luban J, Hair LS, Steinman RM. Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication. J Exp Med 1983; 158: 174–91. 16 Coutinho A, Möller G. Thymus-independent B cell induction and paralysis, Adv Immunol 1975; 21: 113–236. 17 Bullock WE, Carlson EM, Gershon RK. The evolution of immunosuppressive cell populations in experimental mycobacterial infection. J Immunol 1978; 120: 1709–16. 18 Suzuki Y, Watanabe N, Kobayashi A. Nonspecific suppression of primary antibody responses and presence of plastic-adherent suppressor cells in Toxoplasma gondii-infected mice. Infect Immun 1981; 34: 30–5. 19 Suzuki Y, Watanabe N, Kobayashi A. Nonspecific suppression of initiation of memory cells in Toxoplasma gondii-infected mice. Infect Immun 1981; 34: 36–42. 20 Suzuki Y, Kobayashi A. Suppression of unprimed T and B cells in antibody responses by irradiation-resistant and plastic-adherent suppressor cells in Toxoplasma gondii-infected mice. Infect Immun 1981; 40: 1–7. 21 Howard JG, Hale C, Liew FY. Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropicana. J Exp Med 1981; 153: 557–68. 22 Colley DGT. Lymphocytes that contribute to the immunoregulation of granuloma formation in chronic murine schistosomiasis. J Immunol 1981; 126: 1465–8. 23 Rocklin RE, Brown AP, Warren KS et al. Factors that modify the cellular-immune response in patients infected by Schistosoma mansoni. J Immunol 1980; 125: 1916–23. 24 Olds GR, Ellner JJ. Modulation of macrophage activation and resistance by suppressor T lymphocytes in chronic murine Schistosoma mansoni infection. J Immunol 1984; 133: 2720–4. 25 Uchyama T, Jacobs DM. Modulation of immune response to bacterial LPS: multifocal effects of LPS induced suppression of the primary antibody response to a T dependent antigen. J Immunol 1978; 121: 2340–6. 26 Uchyama T, Jacobs DM. Modulation of the immune response to bacterial LPS: cellular basis of the stimulatory and inhibitory effect of LPS on the in vitro IgM antibody response to a T dependent antigen. J Immunol 1978; 121: 2347–51. 27 Fleischer B, Schrezenmeier HT. Cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirements for major histocompatibility complex class II molecules on accessory target cells. J Exp Med 1988; 167: 1697–707. 28 Arala-Chaves MP, Ribeiro AS, Santarem MMG, Coutinho A. Strong mitogenic effect for murine B lymphocytes of an immunosuppressor substance released by Streptococcus intermedius. Infect Immun 1986; 54: 543–8. 29 Santarem MMG, Porto MT, Ferreira P, Soares R, Arala-Chaves MP. Semi-purification of an immunosuppressor substance secreted by Streptococcus mutans which plays a role in the protection of the bacteria in the host. Scand J Immunol 1987; 26: 755–61. 30 Ferreira P, Soares R, Ribeiro A, Arala-Chaves MP. Correlation between specific immunosuppression and polyclonal B cell activation induced by a protein secreted by the Streptococcus mutans. Scand J Immunol 1978; 27: 549–54. 31 Dwyer JM, Bullock WE, Fields JP. Disturbance of the blood T B lymphocyte ratio in lepromatous leprosy. New Engl J Med 1973; 288: 1036–9. 32 Bullock WE, Watson S, Nelson KE, Schauf V, Makonkawkeyoon S, Jacobson RR. Aberrant immunoregulatory control of B lymphocyte function in lepromatous leprosy. Clin Exp Immunol 1982; 49: 105–14. 33 Mahon AC, Gebre N, Nurlign A. The responses of human B cells to Mycobacterium leprae. Identification of target antigens following polyclonal activation in vitro. Int Immunol 1990; 2: 803–12. 34 Harboe M. Significance of antibody studies in leprosy and experimental models of the disease. Int J Lepr 1982; 50: 342–50. 35 Hoffenbach A, Lagrange PH, Bach M-A. Strain variation of lymphokine production and specific antibody secretion in mice infected with Mycobacterium lepraemurium. Cell Immunol 1985; 91: 1–11. 36 Ferreira P, Soares R, Arala-Chaves M. Susceptibility to infection with Mycobacterium avium is paradoxically correlated with increased synthesis of specific anti-bacterial antibodies, Int Immunol 1991; 3: 445–52. 37 Kizaka S, Goodman-Snitkoff G, Mcsharry JJ. Sendai virus glycoproteins are T cell-dependent B cell mitogens. Infect Immun 1983; 40: 592–600. 38 Goodman-Snitkoof G, Mcsharry JJ. Mitogenic activity of Sindbis virus and its isolated glycoproteins. Infect Immun 1982; 38: 1242–8. 39 Coutelier JP, Van Snick J. Isotypically restricted aviation of B lymphocytes by lactic dehydrogenase virus. Eur J Immunol 1985; 15: 250–5. 40 Arala-Chaves MP, Ribeiro AS, Vilanova M, Porto MT, Santarem MMG, Lima M. Correlation between B-cell mitogenicity and immunosuppressor effects of a protein released by porcine monocytes infected with African swine fever virus. Am J Vet Res 1988; 49: 1955–61. 41 Yowell RL, Cole BC, Daynes RA. Utilization of T cell hybridomas to establish that a soluble factor derived from Mycoplasma arthritidis is truly a genetically restricted polyclonal T cell activator, J Immunol 1983; 131: 543–5. 42 Império-Lima MR, Joskowicz M, Coutinho A, Kipnis HL, Eisen H. Very large and isotypically atypical polyclonal PFC responses in mice infected with Trypanosoma cruzi. Eur J Immunol 1985; 15: 201–3. 43 Minoprio MP, Eisen H, Forni L. Império-Lima MR, Joskowicz M, Coutinho A. Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T and B cell response. Scand J Immunol 1986; 24: 661–8. 44 Minoprio MP, Coutinho A, Joskowicz M, Império-Lima MR, Eisen H. Polyclonal lymphocytes responses to murine Trypanosoma cruzi infection. II. Cytotoxic T lymphocytes, Scand J Immunol 1986; 24: 669–79. 45 Sacks DL, Scott PA, Asofsky R, Sher FA. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J Immunol 1984; 132: 2072–7. 46 Império Lima MR, Bandeira A, Falanga P et al. Clonal analysis of B lymphocyte responses to Plasmodium chabaudi infection of normal and immunoprotected mice. Int Immun 1991; 3: 1207–16. 47 Lopes LM, Pereira MAC, Gerken SE, Vaz N. Polyclonal B activation of B lymphocytes during experimental infection with Schistosoma mansoni. Parasitology 1990; 100: 83–91. 48 Arala-Chaves MP, Higerd TB, Porto MT et al. Evidence for the synthesis and release of strongly immunosuppressive substances by Streptococcus intermedius. J Clin Invest 1979; 64: 871–3. 49 Arala-Chaves MP, Porto MP, Arnaud P et al. Fractionation and characterization of the immuno-suppressive substance in crude extracellular products released by Streptococcus intermedius, J Clin Invest 1981; 68: 294–302. 50 Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead lo different functional properties. Ann Rev Immunol 1974; 7: 145–73. 51 Muller I, Garcia-Sanz JA, Titus R, Benin R, Louis J. Analysis of the cellular parameters of the immune responses contributing to resistance and susceptibility of mice to infection with the intracellular parasite. Leishmania major. Immunol Rev 1989; 112: 95–113. 52 Coffman RL, Mosmann TR. CD4+ T-cell subset: regulation of differentiation and function. In: 35th Forum in Immunology, Res Immunol 1991; 142: 78. 53 Powrie F, Fowell D, McKnight AJ, Mason D. Lineage relationships and functions of CD4+ T-cell subsets in the rat. In: 35th Forum in immunology. Res Immunol 1991; 142: 54–8. 54 Pearce EJ, Caspar P, Grzych JP, Lewis FA, Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth. Schistosoma mansoni. J Exp Med 1991; 173: 159–66. 55 Bogdan C, Schroppel K, Lohoff M, Rollinghoff M, Solbach W. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells. Eur J Immunol 1990; 20: 2533–40. 56 Liew FY, Millot SM, Schmidt JA. A repetitive peptide of leishmania can activate T helper type 2 cells and enhance disease progression. J Exp Med 1990; 172: 1359–65. 57 Spinella S, Millon G, Hontebeyrie-Joskowicz MA. CD4+ Th2 cell line isolated from mice chronically infected with Trypanosoma cruzi induces IgG2 polyclonal response in vivo. Eur J Immunol 1990; 20: 1045–51. 58 Ribeiro AS, Arala-Chaves MP, Vilanova M, Porto MT, Coutinho A. Role of B and T lymphocytes in the specific immunosuppression induced by a protein released by porcine monocytes infected with African swine fever virus. Int Immunol 1991; 3: 165–74. 59 Soares R, Ferreira P, Santarem MMG, Silva MT, Arala-Chaves M. Low T- and B-cell reactivity is an apparently paradoxical request for murine immuno-protection against Streptococcus mutans, Murine protection can be achieved by immunization against a B-cell mitogen produced by these bacteria. Scand J Immunol 1990; 31: 361–2. 60 Fiorentine DF, Bond MW, Mosmann TR. Two types of mouse T helper cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081–95. 61 Minoprio P, Coutinho A, Spinella S, Hontebeyne M. The Xid immunodeficiency imparts increased parasite clearance and persistence to pathology in experimental Chagas' disease. In Immun 1991; 3: 427–33. 62 Grun JL, Weidanz WP. Immunity to Plasmodium chabaudi adami in the B-cell-deficient mouse. Nature 1981; 290: 143–5. 63 Eling WH, Jerusalem C. Active immunization against the malaria parasite Plasmodium berghei in mice: sulphatiazole treatment of a P. berghei infection and development of immunity, Tropenmedizin und Parasitologie 1977; 28: 158–74. 64 Eling WH. Plasmodium berghei premonition, sterile immunity and loss of immunity in mice. Exp Parasitol 1980; 49: 89–96. 65 Schlesinger JJ, Brandriss MW. Growth of 17D yellow fever in a macrophage-like cell line. U937: role of Fc and viral receptors in antibody-mediated infection. J Immunol 1981; 127: 659–65. 66 Peiris JSM, Portefield JS. Antibody-mediated enhancement of flavivirus replication in macrophage-like cell line. Nature 1979; 282: 509–12. 67 Takeda A, Tuazon CU, Enniz FA. Antibody-enhancement infection by HIV-1 via Fc receptor-mediated entry. Science 1988; 242: 580–3. 69 Amadori A, Chieco-Bianehi L. B-cell activation and HIV-1 infection: deeds and misdeeds. Immunol Today 1990; 11: 374–9. 69 Howard JG, Hale C, Liew FY. Immunological regulation of experimental cutaneous leishmaniasis and diffuse cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica. J Exp Med 1980; 152: 594–607. 70 Kasper LH, Currie KM, Bradley MS. An unexpected response to vaccination with a purified major membrane tachyzoite antigen (p30) of Toxoplasma gondii. J Immunol 1985; 134: 3426–31. 71 Sundblad A, Huetz F, Portnoi D, Coutinho A. Stimulation of B and T cells by in vivo high dose immunoglobulin administration in normal mice. J Auto Immun 1991; 4: 325–39. Citing Literature Volume35, Issue5May 1992Pages 495-500 ReferencesRelatedInformation